Gram-Positive Cocci
Catalase, coagulase, hemolysis - the branching algorithm
The identification algorithm
Three bench tests. Catalase, coagulase, and hemolysis turn a smear of gram-positive cocci into a named organism. Catalase breaks down hydrogen peroxide: staphylococci (usually seen in clusters) make it, while streptococci and enterococci (chains or pairs) do not. Each branch then has its own discriminating test.
- CatalasePositive → Staphylococcus; negative → Streptococcus/Enterococcus
- Staph: coagulasePositive → S. aureus; negative → novobiocin splits S. epidermidis (sensitive) from S. saprophyticus (resistant)
- Strep: hemolysisAlpha (partial, green), beta (complete, clear), or gamma (none/variable)
- Alpha: optochin and bileS. pneumoniae sensitive and bile-soluble; viridans resistant and insoluble
- Beta: bacitracinGroup A sensitive; group B resistant
- Group D: 6.5% NaClEnterococcus grows; S. gallolyticus does not (both grow in bile)
| Organism | Hemolysis | Key test | Classic disease |
|---|---|---|---|
| S. pneumoniae | Alpha | Optochin-sensitive, bile-soluble, quellung-positive | Meningitis, otitis media, pneumonia, sinusitis |
| Viridans (S. mutans, S. sanguinis) | Alpha | Optochin-resistant, bile-insoluble | Dental caries, subacute endocarditis |
| Group A (S. pyogenes) | Beta | Bacitracin-sensitive, PYR-positive | Pharyngitis, skin infection, scarlet fever |
| Group B (S. agalactiae) | Beta | Bacitracin-resistant, CAMP- and hippurate-positive | Neonatal meningitis, pneumonia, sepsis |
| Enterococcus | Gamma/variable | Grows in bile and 6.5% NaCl | UTI, biliary infection, endocarditis |
| S. gallolyticus | Gamma/variable | Grows in bile, not 6.5% NaCl | Bacteremia/endocarditis with colorectal cancer |
Staphylococcus aureus
Identity and virulence. S. aureus is catalase-positive, coagulase-positive, and beta-hemolytic, with golden colonies; it commonly colonizes the anterior nares. Coagulase converts fibrinogen to fibrin, helping wall off abscesses. Protein A binds the Fc portion of IgG, blocking opsonization and complement activation.
Invasive disease. Skin abscesses, osteomyelitis, septic arthritis, acute endocarditis (tricuspid valve in IV drug users), and post-viral pneumonia, classically after influenza.
| Toxin | Mechanism | Disease |
|---|---|---|
| TSST-1 | Superantigen: cross-links MHC II to the TCR, flooding the body with IL-2 and IFN-γ | Toxic shock: fever, rash, desquamation, hypotension, even without bacteremia (tampons, nasal packing) |
| Exfoliative toxin | Cleaves desmoglein-1 in the superficial epidermis | Scalded skin syndrome, mainly in young children |
| Panton-Valentine leukocidin | Pore-forming toxin that kills leukocytes | Necrotizing MRSA pneumonia |
| Enterotoxin | Preformed in food, heat-stable | Food poisoning 2–6 hours after eating |
Food poisoning. Symptoms begin 2–6 hours after eating contaminated mayonnaise, meats, or dairy because the enterotoxin is already preformed in the food; reheating does not destroy it, and no bacterial growth in the host is needed. Vomiting is prominent, and the illness is short and self-limited.
MRSA. Resistance comes from mecA, which encodes an altered penicillin-binding protein (PBP2a) with low affinity for β-lactams. Serious infections are treated with vancomycin; linezolid and daptomycin are alternatives (daptomycin is inactivated by surfactant, so it is not used for pneumonia).
Coagulase-negative staphylococci
S. epidermidis. A novobiocin-sensitive skin commensal that forms biofilm on prosthetic joints, heart valves, and catheters. It is a common contaminant of blood cultures, so a single positive bottle is interpreted with caution; true device infections are often methicillin-resistant and treated with vancomycin.
S. saprophyticus. Novobiocin-resistant; the second most common cause of UTI in young women, after E. coli.
NO StRESs: Novobiocin – Saprophyticus Resistant, Epidermidis Sensitive.
Beta-hemolytic streptococci: groups A and B
Group A (S. pyogenes). Beta-hemolytic, bacitracin-sensitive, and PYR-positive. M protein is antiphagocytic and drives molecular mimicry. Streptolysin O is the antigen behind the ASO titer, and pyrogenic (erythrogenic) exotoxin produces the sandpaper rash and strawberry tongue of scarlet fever. Diseases: pharyngitis, impetigo, cellulitis, erysipelas, necrotizing fasciitis, and scarlet fever; penicillin remains the treatment of choice.
| Feature | Rheumatic fever | PSGN |
|---|---|---|
| Mechanism | Type II: anti-M protein antibodies cross-react with myosin | Type III: immune complexes |
| Preceding infection | Pharyngitis only | Pharyngitis or skin (impetigo) |
| Antibiotics | Treating the strep prevents it | NOT prevented by antibiotics |
| Presentation | Jones criteria: carditis, polyarthritis, chorea, erythema marginatum, subcutaneous nodules | Cola-colored urine, periorbital edema, hypertension, low C3 |
Group B (S. agalactiae). Beta-hemolytic, bacitracin-resistant, CAMP-test positive, and hippurate positive. It colonizes the vagina and causes neonatal meningitis, pneumonia, and sepsis. Pregnant women are screened with a vaginal-rectal culture at 36 0/7–37 6/7 weeks (ACOG 2019; older CDC guidance used 35–37 weeks), and colonized women receive intrapartum penicillin prophylaxis.
Alpha-hemolytic and group D organisms
S. pneumoniae. An alpha-hemolytic, optochin-sensitive, bile-soluble, lancet-shaped diplococcus. Its polysaccharide capsule (positive quellung reaction) is the main virulence factor, aided by IgA protease. MOPS: leading cause of Meningitis, Otitis media, Pneumonia (lobar, rusty sputum), and Sinusitis. As an encapsulated organism it is especially dangerous in asplenia and sickle cell disease; conjugate and polysaccharide vaccines target the capsule.
Viridans streptococci. S. mutans and S. sanguinis are alpha-hemolytic but optochin-resistant and bile-insoluble, which separates them from pneumococcus. These oral commensals cause dental caries (S. mutans) and subacute endocarditis after dental work: S. sanguinis makes dextran that lets it adhere to fibrin on damaged valves.
Enterococcus. E. faecalis and E. faecium are hardy group D organisms that grow in bile and 6.5% NaCl. As gut flora they cause UTI, biliary infection, and subacute endocarditis after GI/GU procedures. They are intrinsically resistant to cephalosporins. Vancomycin-resistant enterococci (VRE), which replace D-Ala-D-Ala with D-Ala-D-Lac, are nosocomial and treated with linezolid or daptomycin.
S. gallolyticus (formerly S. bovis). A non-enterococcal group D streptococcus that grows in bile but not in 6.5% NaCl. Bacteremia or endocarditis with it is associated with colorectal cancer and should prompt colonoscopy.
Bovis in the blood, cancer in the colon.